Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest Articles2-18F-Fluoropropionic Acid as a PET Imaging Agent for Prostate Cancer
The Journal of Nuclear Medicine, 09/22/09
Pillarsetty N et al. – The data presented here indicate that 18F–FPA accumulates in prostate cancers with high tumor–to–background ratios. 18F–FPA has potential for use in the clinical diagnosis of prostate cancer in humans.
Related Articles
Coincidental Presentations of Ganglioneuroma and Atypical Perforated Appendicitis Detected by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
Clinical Nuclear Medicine, 10/07/09
Relevance Score: 68%
Unusual Finding of Benign Abrikossoff Tumor by F-18 FDG-PET Mimicking Melanoma Recurrence
Clinical Nuclear Medicine, 10/07/09
Relevance Score: 68%
Detection of Metastatic Cervical Lymph Nodes in Recurrent Papillary Thyroid Carcinoma: Computed Tomography Versus Positron Emission Tomography-Computed Tomography
Journal of Computer Assisted Tomography, 10/01/09
Relevance Score: 68%
Prostate Cancer: Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/09/09
Relevance Score: 67%
A suspected [18F]fluorodeoxyglucose positron emission tomography-negative metastatic lymph node successfully diagnosed by laparoscopic staging in esophageal cancer: Report of two cases
Surgery Today, 10/09/09
Relevance Score: 66%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09
Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature
European Urology, 12/04/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Diffuse lymphangiomatosis with genital involvement--evaluation with magnetic resonance lymphangiography
Urologic Oncology: Seminars and Original Investigations, 12/04/09
The Ultimate Prostate Cancer Biopsy Decision Support Tool
European Urology, 12/04/09
Diagnostic Value of Multislice Computed Tomography and Magnetic Resonance Imaging in the Diagnosis of Retroperitoneal Spread of Testicular Cancer
Acta Radiologica, 12/04/09
Article Search
Sponsor